NCCR AntiResist panel discussion
Antibiotic development is a notoriously complex process, with multiple scientific, regulatory, legal, financial and commercial obstacles to be considered before patients can access any successful new antibiotic. Disperazol Pharma’s CEO, Dr. Michael Graz will join Prof. Dr. Urs Jenal from NCCR AntiResist, Dr. Silke Alt from INCATE and Prof. Kevin Outterson from CARB-X to share insights about the unique challenges of […]
MediWales Innovation Awards 2023
It was a real pleasure to present the Start Up Award to @ambrosehlthcare at the #mediwales Innovation Awards on 7 December 2023. Start-up companies are close to our heart at Biophys, so we were delighted that James Preece was able to be at the celebrations and present this award. Ambrose Healthcare is a specialist rare disease pharmaceutical company that aims to match […]
Doing the maths: Disperazol® = cystic fibrosis – (biofilms+AMR)
It was a pleasure and a privilege to attend and present the work of #Disperazol® at the 2023 North American Cystic Fibrosis Conference in Arizona from 2 to 4 November. This was our first opportunity to attend an NACFC conference and it definitely lived up to expectations. Eleven different topic tracks in the programme covered all aspects of […]
MediWales Members’ Showcase 2023
Michael Graz and James Preece are excited to be catching up with old friends and new colleagues in Cardiff at the MediWales Members’ Showcase on 11 October. They will be sharing details about some of our recent work. Join Michael and James in the morning session to find out more.
Biophys at the Nordic Innovation Fair 2023
We are really pleased to be at the Nordic Innovation Fair at Copenhagen Science City this morning where we will be presenting an update of our work with Disperazol, a novel antibiofilm compound that dismantles biofilms. Come and listen to @biophys_michael in Rooms 7&9 at 10:10 to hear more.
Disperazol® features at the 7th AMR Conference in Basel
It is that time of the year again when the attention of the global AMR community shifts to Basel, Switzerland. The BEAM Alliance’s 7th AMR Conference will take place again in Basel on 16 and 17 March 2023. This premier event showcases research and development of novel antimicrobials and diagnostics that are aimed specifically at […]
Meet us at BioWales in London 2023
We are delighted to be able to be part of MediWales’s annual #BioWalesLondon meeting from 9am to 6pm on Tuesday 14 March. BioWales in London is a showcase of Welsh life science and healthtech that also builds links with the broader UK life sciences community. From past experience, conversations started at BioWales meetings have sparked collaboration and innovation between […]
Biophys present at BioWales in London 2022
This week, we’re reminiscing on a big milestone in the recent history of Biophys Ltd last month when the MediWales-organised BioWales in London conference took place marking a return to in-person networking events following the Covid-19 pandemic. On 9th March 2022 the annual BioWales in London conference was held to coincide with Wales in London […]
Find us at BioWales in London this month
Biophys is a proud member of the independent Life Science Network for Wales, MediWales. Founded in 1992, working on behalf of the Welsh life science sector, they are a not-for-profit limited company helping to create opportunities, partnerships, supporting global trade development, improving access to clinical expertise and engaging with the government to increase support for […]
Biophys Present Outstanding Achievement Award at MediWales Innovation Awards 2021
Biophys are delighted to have presented the Outstanding Achievement Award to BiVictriX Therapeutics at the sixteenth annual MediWales Innovation Awards on 2nd December 2021. The prestigious awards ceremony was held at the Mercure Holland House Hotel in Cardiff and is designed to recognise the achievements of the life science network and representative body for Wales, […]
Biophys attends Virtual AMR Innovation Mission 2021
The value of accurate, cost-effective diagnostics that can be rolled out globally and used easily was shown by COVID-19. The need for correct, quick diagnosis of infectious diseases is as great for #AMR. Follow the discussion from 10-12 May at the Virtual AMR Innovation Mission 2021 https://bit.ly/2SyKDn7